{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T17:07:28Z","timestamp":1725469648242},"publisher-location":"Chichester, UK","reference-count":62,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006682.pub3","type":"reference-entry","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T00:48:50Z","timestamp":1294274930000},"source":"Crossref","is-referenced-by-count":3,"title":["Duration of intravenous antibiotic therapy in people with cystic fibrosis"],"prefix":"10.1002","author":[{"given":"Amanda","family":"Plummer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wildman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,19]]},"reference":[{"issue":"18","key":"10.1002\/14651858.CD006682.pub3-BIB1|cit1","first-page":"1614","article-title":"Intravenous administration of antibiotics at home in patients with cystic fibrosis improves quality of life","volume":"85","author":"Hjelte","year":"1988","journal-title":"Lakartidningen"},{"issue":"9","key":"10.1002\/14651858.CD006682.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1128\/AAC.00174-09","article-title":"Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis","volume":"53","author":"Hubert","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD006682.pub3-BIB3|cit3","series-title":"Proceedings of 20th European Cystic Fibrosis Conference; 1995 June 18-21; Brussels, Belgium","first-page":"P19","article-title":"Quinoline therapy in children with cystic fibrosis [abstract]","author":"Kapranov","year":"1995"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006682.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"S39, Abstract n","DOI":"10.1016\/S1569-1993(09)60158-2","article-title":"Eradication of Pseudomonas aeruginosa in adults with CF [abstract]","volume":"8","author":"Kenny","year":"2009","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD006682.pub3-BIB5|cit5","series-title":"Proceedings of 9th Meeting European Working Group for Cystic Fibrosis; 1979 June 12-13; Noordwijkerhout, The Netherlands","first-page":"52","article-title":"A double blind trial of cephalexin in cystic fibrosis patients with pseudomonas in the sputum [abstract]","author":"Knight","year":"1979"},{"issue":"2","key":"10.1002\/14651858.CD006682.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jcf.2007.07.001","article-title":"Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis","volume":"7","author":"Latzin","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006682.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S1569-1993(07)60126-X","article-title":"A prospective trial on the efficacy and tolerability of twice-daily dosing (TDD) versus once-daily dosing (ODD) amikacin in cystic fibrosis patients [abstract]","volume":"6","author":"Postnikov","year":"2007","journal-title":"Journal of Cystic Fibrosis"},{"issue":"9484","key":"10.1002\/14651858.CD006682.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(05)67060-2","article-title":"Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial","volume":"366","author":"Aaron","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD006682.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00063198-199711000-00002","article-title":"Early pulmonary disease in cystic fibrosis","volume":"3","author":"Accurso","year":"1997","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"6994","key":"10.1002\/14651858.CD006682.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1136\/bmj.310.6994.1571","article-title":"Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis","volume":"310","author":"Armstrong","year":"1995","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD006682.pub3-BIB11|cit11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001917.pub2","article-title":"Home Intravenous antibiotics for cystic fibrosis (Cochrane Review)","author":"Balaguer","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006682.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3476(80)80155-7","article-title":"Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?","volume":"97","author":"Beaudry","year":"1980","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD006682.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/jac\/dkl328","article-title":"Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?","volume":"58","author":"Burkhardt","year":"2006","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD006682.pub3-BIB14|cit14","unstructured":"Cystic Fibrosis Foundation Microbiology and Infectious disease in cystic fibrosis Consensus Conference, Bethesda 1994 1 26"},{"key":"10.1002\/14651858.CD006682.pub3-BIB15|cit15","unstructured":"Cystic Fibrosis Foundation National Patient Registry Annual Data Report 2000 [Bethesda, Maryland] 2001"},{"key":"10.1002\/14651858.CD006682.pub3-BIB16|cit16","unstructured":"UK Cystic Fibrosis Trust Antibiotic Group Antibiotic treatment for Cystic Fibrosis Report of the UK Cystic Fibrosis Trust Antibiotic Group 2009"},{"issue":"9041","key":"10.1002\/14651858.CD006682.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0140-6736(05)66225-3","article-title":"Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic","volume":"348","author":"Cheng","year":"1996","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD006682.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0895-4356(94)00230-N","article-title":"Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection","volume":"48","author":"Demko","year":"1995","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD006682.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1183\/09031936.00099506","article-title":"Cystic fibrosis mortality and survival in the UK: 1947-2003","volume":"29","author":"Dodge","year":"2007","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD006682.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00063198-200311000-00007","article-title":"Update on pathogenesis of cystic fibrosis lung disease","volume":"9","author":"Donaldson","year":"2003","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006682.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"Doring","year":"2000","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD006682.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcf.2003.12.007","article-title":"Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation","volume":"3","author":"Edenborough","year":"2004","journal-title":"Journal of Cystic Fibrosis"},{"issue":"11","key":"10.1002\/14651858.CD006682.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/thx.2003.017285","article-title":"Difficult bacteria, antibiotic resistance and transmissibility in cystic fibrosis","volume":"59","author":"Elborn","year":"2004","journal-title":"Thorax"},{"issue":"1","key":"10.1002\/14651858.CD006682.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD006682.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatric Pulmonology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD006682.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1164\/ajrccm.160.5.9805046","article-title":"Burkholderia cepacia in cystic fibrosis: variable disease course","volume":"160","author":"Frangolias","year":"1999","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"8","key":"10.1002\/14651858.CD006682.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD006682.pub3-BIB28|cit28","first-page":"93","article-title":"Microbiology of CF Lung Disease","volume-title":"Cystic Fibrosis in Adults","author":"Gilligan","year":"1999"},{"key":"10.1002\/14651858.CD006682.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-3476(87)80217-2","article-title":"Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis","volume":"111","author":"Gold","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD006682.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jcf.2008.06.009","article-title":"Early aggressive eradication therapy for intermittent Pseudomonas Aeruginosa airway colonisation in cystic fibrosis patients: 15 years experience","volume":"7","author":"Hansen","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"issue":"18","key":"10.1002\/14651858.CD006682.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/JB.183.18.5395-5401.2001","article-title":"Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function","volume":"183","author":"Hentzer","year":"2001","journal-title":"Journal of Bacteriology"},{"issue":"7414","key":"10.1002\/14651858.CD006682.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006682.pub3-BIB33|cit33","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"volume-title":"Cystic Fibrosis","year":"2000","author":"Hodson","key":"10.1002\/14651858.CD006682.pub3-BIB34|cit34"},{"issue":"6","key":"10.1002\/14651858.CD006682.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000056287","article-title":"Treatment of cystic fibrosis in the adult","volume":"67","author":"Hodson","year":"2000","journal-title":"Respiration"},{"issue":"2","key":"10.1002\/14651858.CD006682.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/12.2.175","article-title":"Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis","volume":"12","author":"Hoogkamp-Korstanje","year":"1983","journal-title":"Journal Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD006682.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000079640","article-title":"Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis. A prospective study","volume":"71","author":"Horre","year":"2004","journal-title":"Respiration"},{"issue":"2","key":"10.1002\/14651858.CD006682.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3476(81)80486-6","article-title":"A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis","volume":"99","author":"Hyatt","year":"1981","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD006682.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00128072-200002060-00004","article-title":"Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis","volume":"2","author":"H\u00f8iby","year":"2000","journal-title":"Paediatric Drugs"},{"issue":"9281","key":"10.1002\/14651858.CD006682.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(01)05714-2","article-title":"Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic","volume":"358","author":"Jones","year":"2001","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD006682.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/thorax.57.11.924","article-title":"Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa","volume":"57","author":"Jones","year":"2002","journal-title":"Thorax"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD006682.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"S608","DOI":"10.1093\/clinids\/13.Supplement_7.S608","article-title":"Retrospective clinical study of hypersensitivity reactions to astreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple antibiotic courses","volume":"13","author":"Koch","year":"1991","journal-title":"Reviews of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006682.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0258(19960315)15:5<449::AID-SIM173>3.0.CO;2-X","article-title":"The incidence of cystic fibrosis","volume":"15","author":"Kosorok","year":"1996","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006682.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000087686","article-title":"Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa","volume":"73","author":"Lechtzin","year":"2006","journal-title":"Respiration"},{"issue":"5","key":"10.1002\/14651858.CD006682.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ppul.1060","article-title":"Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study","volume":"31","author":"Master","year":"2001","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD006682.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/infdis\/147.3.559","article-title":"Clinical and bacteriological responses to three antibiotic regimens for acute exacerbation of cystic fibrosis: Ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo","volume":"147","author":"McLaughlin","year":"1983","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006682.pub3-BIB47|cit47","first-page":"761","article-title":"Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum","volume":"132","author":"Mendelman","year":"1985","journal-title":"American Review of Respiratory Disease"},{"issue":"12","key":"10.1002\/14651858.CD006682.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/ppul.20517","article-title":"Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic","volume":"41","author":"Olesen","year":"2006","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD006682.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/thx.2004.027953","article-title":"Antibiotic allergy in cystic fibrosis","volume":"60","author":"Parmar","year":"2005","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD006682.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0007-0971(83)90025-6","article-title":"Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis","volume":"77","author":"Penketh","year":"1983","journal-title":"British journal of diseases of the chest"},{"issue":"4","key":"10.1002\/14651858.CD006682.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/thx.39.4.299","article-title":"Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis","volume":"39","author":"Penketh","year":"1984","journal-title":"Thorax"},{"issue":"7","key":"10.1002\/14651858.CD006682.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/thx.42.7.526","article-title":"Cystic fibrosis in adolescents and adults","volume":"42","author":"Penketh","year":"1987","journal-title":"Thorax"},{"issue":"5","key":"10.1002\/14651858.CD006682.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1651-2227.1981.tb05757.x","article-title":"Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma - possible synergism with Pseudomonas aeruginosa","volume":"70","author":"Petersen","year":"1981","journal-title":"Acta Paediatrica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD006682.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ppul.20023","article-title":"Pulmonary exacerbation in cystic fibrosis","volume":"37","author":"Rabin","year":"2004","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD006682.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJM199607183350307","article-title":"Management of pulmonary disease in patients with cystic fibrosis","volume":"335","author":"Ramsey","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006682.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ppul.1950160404","article-title":"Predictive value of pulmonary function testing during pulmonary exacerbations in cystic fibrosis","volume":"16","author":"Rosenberg","year":"1993","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD006682.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ppul.10100","article-title":"Predictors of deterioration of lung function in cystic fibrosis","volume":"33","author":"Schaedel","year":"2002","journal-title":"Pediatric Pulmonology"},{"issue":"9459","key":"10.1002\/14651858.CD006682.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(05)17906-9","article-title":"Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial","volume":"365","author":"Smyth","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD006682.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"816","DOI":"10.7326\/0003-4819-143-11-200512060-00010","article-title":"Pathogenesis of early lung disease in cystic fibrosis: A window of opportunity to eradicate bacteria","volume":"143","author":"Starner","year":"2005","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006682.pub3-BIB60|cit60","first-page":"117","article-title":"Early eradication of Pseudomonas Aeruginosa in Patients with Cystic Fibrosis. Review Article","volume":"11","author":"Stuart","year":"2010","journal-title":"Peadiatric Respiratory Reviews"},{"issue":"6","key":"10.1002\/14651858.CD006682.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/adc.78.6.536","article-title":"Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis","volume":"78","author":"Vic","year":"1998","journal-title":"Archives of Disease in Childhood"},{"issue":"930","key":"10.1002\/14651858.CD006682.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/pmj.79.930.201","article-title":"Impact of respiratory viral infections on cystic fibrosis","volume":"79","author":"Wat","year":"2003","journal-title":"Postgraduate Medical Journal"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006682.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:02:39Z","timestamp":1628532159000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006682.pub3"}},"subtitle":[],"editor":[{"given":"Amanda","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,19]]},"references-count":62,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006682.pub3","relation":{},"subject":[],"published":{"date-parts":[[2011,1,19]]}}}